COPAXONE Side Effects

7010435-9 | Aortic Valve Disease, Cataract, Fluid Retention, Mitral Valve Disease, Myalgia, Temporal Arteritis
on Sep 16, 2010 Female patient from UNITED STATES , weighting 160.9 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?), palpitations, sleep disorder (What is sleep disorder?), anxiety (What is anxiety?), hypertension and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: aortic valve disease, cataract (What is cataract?), fluid retention, mitral valve disease, myalgia, temporal arteritis. Copaxone dosage: . During the same period patient was treated with INTERFERON BETA 1A (View Interferon Beta-1a Review and Interferon Beta-1a Label ), INTERFERON BETA 1A (View Interferon Beta-1a Review and Interferon Beta-1a Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

7006597-X | Injection Site Reaction
Patient was taking Copaxone (View Usage). Patient had the following side effects: injection site reaction on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 41 years of age, weighting 199.0 lb, was diagnosed with relapsing-remitting multiple sclerosis and. Copaxone dosage: 20 Mg Daily Iv.

7004931-8 | Staphylococcal Infection
Adverse event was reported on Sep 17, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , weighting 165.1 lb, After Copaxone was administered, patient had the following side effects: staphylococcal infection (What is staphylococcal infection?). During the same period patient was treated with FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), AMANTADINE HYDROCHLORIDE (View Amantadine Hydrochloride Review and Amantadine Hydrochloride Label ).

7002921-2 | Optic Neuritis
on Sep 15, 2010 Female patient from UNITED STATES , 53 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: optic neuritis. Copaxone dosage: .


6992382-1 | Breast Cancer
on Sep 14, 2010 Female patient from UNITED STATES , 71 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Copaxone dosage: .

6983400-5 | Platelet Count Decreased
Patient was taking Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: platelet count decreased on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: 20 Mg Daily Sq.

6969559-4 | Abscess, Cellulitis, Injection Site Infection, Mycobacterial Infection, No Therapeutic Response
Adverse event was reported on Sep 07, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: 20 Mg Daily Sq) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 55 years of age, weighting 195.0 lb, Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), cellulitis (What is cellulitis?), injection site infection, mycobacterial infection, no therapeutic response. Patient was hospitalized.

6945295-5 | Pancreatitis
on Aug 20, 2010 Male patient from UNITED STATES , 61 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: pancreatitis. Copaxone dosage: . During the same period patient was treated with INTERFERON BETA 1A (View Interferon Beta-1a Review and Interferon Beta-1a Label ).

6940197-2 | Urticaria
on Aug 16, 2010 Male patient from UNITED STATES , 45 years of age, weighting 200.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: urticaria. Copaxone dosage: . During the same period patient was treated with AMPYRA (View Ampyra Review and Ampyra Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ).

6921754-6 | Pulmonary Embolism
Patient was taking Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?) on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), epilepsy (What is epilepsy?) and. Copaxone dosage: . Patient was hospitalized.

6917619-6 | Small For Dates Baby
Adverse event was reported on Jul 27, 2010 by a Male patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: SWEDEN , weighting 2.09 lb, Patient had the following side effects: small for dates baby. Patient was hospitalized.

6917539-7 | Haematoma, Injection Site Atrophy
on Aug 06, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: haematoma, injection site atrophy. Copaxone dosage: .

6913698-0 | Back Pain, Chills, Dyspnoea, Gait Disturbance, Nausea, Pain In Extremity, Syncope, Throat Tightness
on Aug 06, 2010 Female patient from UNITED STATES , 54 years of age, weighting 205.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), chills, dyspnoea, gait disturbance, nausea (What is nausea?), pain in extremity, syncope, throat tightness. Copaxone dosage: 20mg 1 Everyday.

6911658-7 | Acute Promyelocytic Leukaemia, Cerebrovascular Accident, Cholecystitis, Deep Vein Thrombosis, Fatigue, Haematemesis, Nausea
Patient was taking Copaxone (View Usage). Patient had the following side effects: acute promyelocytic leukaemia, cerebrovascular accident, cholecystitis, deep vein thrombosis (What is deep vein thrombosis?), fatigue, haematemesis, nausea (What is nausea?) on Aug 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 286.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (Once Every 3 Months) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ). Patient was hospitalized.

6908197-6 | Convulsion, Pancreatitis
Adverse event was reported on Jul 26, 2010 by a Male patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 42 years of age, After Copaxone was administered, patient had the following side effects: convulsion, pancreatitis. During the same period patient was treated with INTERFERON BETA (View Interferon Beta Review and Interferon Beta Label ). Patient was hospitalized.

6883008-6 | Haematoma, Injection Site Atrophy
on Jul 22, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, injection site atrophy. Copaxone dosage: .

6880035-X | Convulsion, Pancreatitis
on Jul 20, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: convulsion, pancreatitis. Copaxone dosage: . During the same period patient was treated with INTERFERON BETA (View Interferon Beta Review and Interferon Beta Label ). Patient was hospitalized.

6877118-7 | Prostate Cancer
Patient was taking Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: prostate cancer (What is prostate cancer?) on Jul 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 237.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: 20 Mgs Qd Sq.

6867570-5 | Prostate Cancer
Adverse event was reported on Jul 22, 2010 by a Male patient taking Copaxone (View Usage) (Dosage: 20 Mg Qd Sq) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , weighting 237.0 lb, Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?).

6862473-4 | Palpitations, Tremor, Weight Increased
on Jul 15, 2010 Female patient from UNITED STATES , 53 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: palpitations, tremor, weight increased. Copaxone dosage: .

6859776-6 | Cardiac Failure
on Jul 12, 2010 Female patient from UNITED STATES , 52 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: cardiac failure. Copaxone dosage: .

6855498-6 | Aphasia, Cerebrovascular Accident, Dysarthria, Hypoaesthesia
Patient was taking Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, dysarthria, hypoaesthesia on Jul 06, 2010 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: .

6855493-7 | Arthralgia, Neck Pain
Adverse event was reported on Jul 12, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 38 years of age, Patient had the following side effects: arthralgia, neck pain.

6855479-2 | Abdominal Discomfort, Chills, Gait Disturbance, Nausea, Neuropathy Peripheral, Pain In Extremity
on Jul 06, 2010 Female patient from UNITED STATES , 22 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: abdominal discomfort, chills, gait disturbance, nausea (What is nausea?), neuropathy peripheral, pain in extremity. Copaxone dosage: .

6855477-9 | Convulsion
on Jul 12, 2010 Male patient from UNITED STATES , 42 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Copaxone dosage: . During the same period patient was treated with INTERFERON BETA (View Interferon Beta Review and Interferon Beta Label ). Patient was hospitalized.

6839893-7 | Injection Site Reaction
Patient was taking Copaxone (View Usage). Patient had the following side effects: injection site reaction on Jun 28, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: .

6839887-1 | Dyspnoea, Headache, Optic Neuritis, Palpitations
Adverse event was reported on Jul 06, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 28 years of age, After Copaxone was administered, patient had the following side effects: dyspnoea, headache (What is headache?), optic neuritis, palpitations.

6836353-4 | Aphonia, Choking Sensation, Muscular Weakness, Mydriasis
on Jul 12, 2010 Female patient from UNITED STATES , 43 years of age, weighting 180.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: aphonia, choking sensation, muscular weakness, mydriasis. Copaxone dosage: . Patient was hospitalized.

6832099-7 | Acute Promyelocytic Leukaemia, Cerebrovascular Accident, Cholecystitis, Deep Vein Thrombosis, Fatigue, Haematemesis, Nausea
on Jul 02, 2010 Male patient from UNITED STATES , weighting 286.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: acute promyelocytic leukaemia, cerebrovascular accident, cholecystitis, deep vein thrombosis (What is deep vein thrombosis?), fatigue, haematemesis, nausea (What is nausea?). Copaxone dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (Once Every 3 Months) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ). Patient was hospitalized.

6831421-5 | Acute Promyelocytic Leukaemia, Cerebrovascular Accident, Cholecystitis, Deep Vein Thrombosis, Fatigue, Haematemesis, Nausea
Patient was taking Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: acute promyelocytic leukaemia, cerebrovascular accident, cholecystitis, deep vein thrombosis (What is deep vein thrombosis?), fatigue, haematemesis, nausea (What is nausea?) on Jul 02, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 286.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (Once Every 3 Months) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ). Patient was hospitalized.

6826794-3 | Road Traffic Accident
Adverse event was reported on Jun 28, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: road traffic accident.

6823343-0 | Chest Pain, Nausea, Paraesthesia
on Jun 15, 2010 Female patient from UNITED STATES , 54 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: chest pain (What is chest pain?), nausea (What is nausea?), paraesthesia. Copaxone dosage: . During the same period patient was treated with ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), TYLOX /00446701/ (View Tylox /00446701/ Review and Tylox /00446701/ Label ).

6819909-4 | Chronic Obstructive Pulmonary Disease, Multiple Sclerosis Relapse
on Jun 28, 2010 Female patient from UNITED STATES , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: chronic obstructive pulmonary disease, multiple sclerosis relapse. Copaxone dosage: . Patient was hospitalized.

6815391-1 | Deafness Unilateral, Injection Site Erythema, Injection Site Pruritus, Injection Site Swelling, Rash Pruritic, Skin Reaction, Urticaria
Patient was taking Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: deafness unilateral, injection site erythema, injection site pruritus, injection site swelling, rash pruritic, skin reaction, urticaria on Jun 21, 2010 from DENMARK Additional patient health information: Female patient , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: .

6814976-6 | Injection Site Mass
Adverse event was reported on Jul 01, 2010 by a Male patient taking Copaxone (View Usage) (Dosage: 20 Mg Daily Big Lumps Back On Rebif) was diagnosed with multiple allergies and. Location: UNITED STATES , weighting 507.1 lb, Patient had the following side effects: injection site mass. Patient was hospitalized.

6813539-6 | Anaphylactic Shock, Dyspnoea, Face Oedema, Throat Tightness
on Jun 23, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: anaphylactic shock, dyspnoea, face oedema, throat tightness. Copaxone dosage: .

6809746-9 | Acute Myeloid Leukaemia
on Jun 17, 2010 Male patient from UNITED STATES , weighting 286.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia. Copaxone dosage: . During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE (Once Every 3 Months) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label ).

6801755-9 | Angioedema, Convulsion, Hypertension, Palpitations
Patient was taking Copaxone (View Usage). Patient had the following side effects: angioedema, convulsion, hypertension, palpitations on Jun 15, 2010 from UNITED STATES Additional patient health information: Female patient , 38 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: . During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ).

6770464-7 | Injection Site Erythema, Injection Site Oedema, Rash Pruritic
Adverse event was reported on Jun 02, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 60 years of age, After Copaxone was administered, patient had the following side effects: injection site erythema, injection site oedema, rash pruritic.

6770459-3 | Herpes Zoster, Multiple Sclerosis Relapse
on May 28, 2010 Female patient from UNITED STATES , 36 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: herpes zoster, multiple sclerosis relapse. Copaxone dosage: .

6765797-4 | Convulsion, Injection Site Pruritus
on May 28, 2010 Female patient from UNITED STATES , 40 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: convulsion, injection site pruritus. Copaxone dosage: .

6763381-X | Abdominal Rigidity, Dysstasia, Gait Disturbance, Hyperhidrosis, Loss Of Consciousness, Muscle Spasms
Patient was taking Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: abdominal rigidity, dysstasia, gait disturbance, hyperhidrosis, loss of consciousness, muscle spasms on Jun 08, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 125.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Copaxone dosage: 20mg Once Daily Sq.

6753045-0 | Chest Pain, Dyspnoea, Flushing, Hyperhidrosis, Immediate Post-injection Reaction, Nausea, Palpitations, Pruritus
Adverse event was reported on Jun 02, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: 20mg/ml Daily 057) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , weighting 225.0 lb, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, flushing, hyperhidrosis, immediate post-injection reaction, nausea (What is nausea?), palpitations, pruritus. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ).

6752777-8 | Abdominal Discomfort, Diarrhoea, Dyspnoea, Lip Swelling, Rash
on Jun 02, 2010 Female patient from UNITED STATES , 24 years of age, weighting 113.3 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient had the following side effects: abdominal discomfort, diarrhoea, dyspnoea, lip swelling, rash (What is rash?). Copaxone dosage: 20 Mg Daily Sq. Patient was hospitalized.

6752776-6 | Asthma, Pain In Extremity, Pneumonia, Tremor
on Jun 02, 2010 Female patient from UNITED STATES , 50 years of age, weighting 152.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: asthma (What is asthma?), pain in extremity, pneumonia (What is pneumonia?), tremor. Copaxone dosage: 20 Mg Daily Im. Patient was hospitalized.

6751594-2 | Pancreatic Carcinoma, Uterine Leiomyoma
Patient was taking Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatic carcinoma, uterine leiomyoma on May 20, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with relapsing-remitting multiple sclerosis and. Copaxone dosage: . Patient was hospitalized.

6751590-5 | Anaemia Haemolytic Autoimmune, Asthenia, Circulatory Collapse, Coombs Test Positive, Dyspnoea
Adverse event was reported on May 19, 2010 by a Female patient taking Copaxone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: GERMANY , weighting 165.3 lb, Patient had the following side effects: anaemia haemolytic autoimmune, asthenia, circulatory collapse, coombs test positive, dyspnoea. During the same period patient was treated with JODTHYROX (View Jodthyrox Review and Jodthyrox Label ). Patient was hospitalized.

6742062-2 | Anaemia Haemolytic Autoimmune, Circulatory Collapse, Coombs Test Positive
on May 17, 2010 Female patient from GERMANY , weighting 165.3 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). After Copaxone was administered, patient had the following side effects: anaemia haemolytic autoimmune, circulatory collapse, coombs test positive. Copaxone dosage: . During the same period patient was treated with JODTHYROX (View Jodthyrox Review and Jodthyrox Label ). Patient was hospitalized.

6739163-1 | Myocarditis
on May 14, 2010 Female patient from UNITED STATES , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Copaxone (View Usage). Patient experienced the following unwanted or unexpected effects: myocarditis. Copaxone dosage: . During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ). Patient was hospitalized.

6738539-6 | Pancreatic Carcinoma, Uterine Leiomyoma
Patient was taking Copaxone (View Usage). Patient had the following side effects: pancreatic carcinoma, uterine leiomyoma on May 07, 2010 from NETHERLANDS Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with relapsing-remitting multiple sclerosis and. Copaxone dosage: . Patient was hospitalized.